FATE logo

Fate Therapeutics (FATE) Short Term Debt

Annual Short Term Debt

$6.18 M
+$548.00 K+9.74%

December 31, 2023


Summary


Performance

FATE Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFATEbalance sheetmetrics:

Quarterly Short Term Debt

$6.89 M
+$249.00 K+3.75%

September 30, 2024


Summary


Performance

FATE Quarterly Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFATEbalance sheetmetrics:

Short Term Debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

FATE Short Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+9.7%+15.3%
3 y3 years+84.1%+24.3%
5 y5 years+153.3%+263.2%

FATE Short Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+10.7%at high+24.3%
5 y5-yearat high+265.0%at high+307.4%
alltimeall time-24.6%+394.9%-55.7%+1028.2%

Fate Therapeutics Short Term Debt History

DateAnnualQuarterly
Sep 2024
-
$6.89 M(+3.7%)
Jun 2024
-
$6.64 M(+3.8%)
Mar 2024
-
$6.40 M(+3.7%)
Dec 2023
$6.18 M(+9.7%)
$6.18 M(+3.3%)
Sep 2023
-
$5.98 M(+3.3%)
Jun 2023
-
$5.79 M(+4.3%)
Mar 2023
-
$5.54 M(-1.5%)
Dec 2022
$5.63 M(+0.9%)
$5.63 M(-2.2%)
Sep 2022
-
$5.75 M(+0.7%)
Jun 2022
-
$5.72 M(+2.4%)
Mar 2022
-
$5.58 M(+0.1%)
Dec 2021
$5.58 M(+66.2%)
$5.58 M(+18.7%)
Sep 2021
-
$4.70 M(-7.3%)
Jun 2021
-
$5.07 M(+14.9%)
Mar 2021
-
$4.41 M(+31.5%)
Dec 2020
$3.35 M(+98.3%)
$3.35 M(+44.0%)
Sep 2020
-
$2.33 M(-1.1%)
Jun 2020
-
$2.35 M(+24.1%)
Mar 2020
-
$1.90 M(+12.2%)
Dec 2019
$1.69 M
$1.69 M(-89.1%)
Sep 2019
-
$15.56 M(+121.7%)
Jun 2019
-
$7.02 M(+36.5%)
DateAnnualQuarterly
Mar 2019
-
$5.14 M(+110.9%)
Dec 2018
$2.44 M(-70.2%)
$2.44 M(-25.3%)
Sep 2018
-
$3.26 M(+62.3%)
Jun 2018
-
$2.01 M(+165.3%)
Mar 2018
-
$758.00 K(-90.1%)
Mar 2017
-
$7.62 M(-6.9%)
Dec 2016
$8.19 M(+8.4%)
$8.19 M(+2.0%)
Sep 2016
-
$8.03 M(+2.0%)
Jun 2016
-
$7.86 M(+2.1%)
Mar 2016
-
$7.71 M(+2.1%)
Dec 2015
$7.55 M(+391.9%)
$7.55 M(+16.3%)
Sep 2015
-
$6.49 M(+26.0%)
Jun 2015
-
$5.16 M(+58.4%)
Mar 2015
-
$3.26 M(+112.1%)
Dec 2014
$1.53 M(-11.4%)
$1.53 M(+151.2%)
Sep 2014
-
$611.00 K(-18.1%)
Jun 2014
-
$746.00 K(-39.8%)
Mar 2014
-
$1.24 M(-28.4%)
Dec 2013
$1.73 M(-10.8%)
$1.73 M(-68.2%)
Sep 2013
-
$5.45 M(+177.9%)
Jun 2013
-
$1.96 M(+1.1%)
Dec 2012
$1.94 M(+55.5%)
$1.94 M
Dec 2011
$1.25 M
-

FAQ

  • What is Fate Therapeutics annual short term debt?
  • What is the all time high annual short term debt for Fate Therapeutics?
  • What is Fate Therapeutics annual short term debt year-on-year change?
  • What is Fate Therapeutics quarterly short term debt?
  • What is the all time high quarterly short term debt for Fate Therapeutics?
  • What is Fate Therapeutics quarterly short term debt year-on-year change?

What is Fate Therapeutics annual short term debt?

The current annual short term debt of FATE is $6.18 M

What is the all time high annual short term debt for Fate Therapeutics?

Fate Therapeutics all-time high annual short term debt is $8.19 M

What is Fate Therapeutics annual short term debt year-on-year change?

Over the past year, FATE annual short term debt has changed by +$548.00 K (+9.74%)

What is Fate Therapeutics quarterly short term debt?

The current quarterly short term debt of FATE is $6.89 M

What is the all time high quarterly short term debt for Fate Therapeutics?

Fate Therapeutics all-time high quarterly short term debt is $15.56 M

What is Fate Therapeutics quarterly short term debt year-on-year change?

Over the past year, FATE quarterly short term debt has changed by +$916.00 K (+15.33%)